Funded Projects in the Human Capital Growth 2024 Funding Round

News October 30, 2025

Good news: six new projects have been awarded funding within the PharmaNL Human Capital Growth (HCG) program line. These projects specifically focus on developing flexible post-secondary, post-bachelor, and post-graduate education tailored to the evolving needs of the pharmaceutical sector.

The PharmaNL Human Capital Growth 2024 call marks the second funding round within the HCG program line. This initiative aims to implement a coherent program that enriches the current pharmaceutical education offerings and, where possible, enhances international appeal and visibility.

Purpose of the Funding Call

The goal of this funding call was to address the themes identified in the PharmaNL Investment Agenda. The funded projects will contribute, among other things, to creating a relevant lifelong learning offer, encouraging professionals in the pharmaceutical sector to further develop their skills and remain active in the field.

Funded Projects

  • QPharmNL: Quantitative Pharmacology Training Program for Drug Development in the Netherlands
    Prof. Dr. Coen van Hasselt, Leiden University

  • IMaging EDucation (IMED)
    Derk Jan de Groot, University Medical Center Groningen

  • From Theory to Practice: Post-Bachelor Education in Innovative Drug Development
    Prof. Dr. Roland Brock, Radboudumc

  • Future-Oriented Training for Cell and Gene Therapy Professionals
    Emma de Pater, Erasmus MC

  • Bridging the Gap: Innovative Continuing Education for Cell and Gene Therapies (CGT)
    Prof. Dr. Niels Geijsen, Leiden University Medical Center

  • Fermentation & Bioprocessing for Smart and Sustainable Pharma
    Drs. Sven Stielstra, LIFE Cooperative

In the coming months, these projects will be launched and showcased on the websites of funding partner ZonMw and PharmaNL—so keep an eye on our site!

Source of text and image: ZonMw